Viewing Study NCT06529770



Ignite Creation Date: 2024-10-25 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06529770
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-26

Brief Title: Ultrasound-Guided Percutaneous Neuromodulation in the Strength of CrossFit Athletes A RCT
Sponsor: None
Organization: None

Study Overview

Official Title: Benefits of Ultrasound-Guided Percutaneous Neuromodulation on the Strength of CrossFit Athletes A Randomized Clinical Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The origin of CrossFit CF dates back to 1995 when Greg Glassman opened the first facility dedicated to the sport he named CF in Santa Cruz California However the dissemination and promotion of this sport began in 2000 with the creation of the CF brand alongside his wife Lauren Jenai Today the brand generates around 100 million euros annually and has a market valuation of approximately 4 billion euros CF boasts 14000 boxes in 155 countries with over five million users Spain ranks as the fifth country with the most CF centers

CF training focuses on constantly varied functional movements including gymnastics weightlifting exercises and cardiovascular activities eg running or rowing Variety is one of the main attractions for participants as the workouts are short intense and diverse

Within invasive physiotherapy there is the technique of ultrasound-guided percutaneous neuromodulation US-PNM which enhances muscle function muscle recruitment patterns and motor control This minimally invasive intervention involves the application of percutaneous electrical stimulation through an electrode similar to an acupuncture needle placed in close proximity to the nerve or motor point of the target muscle under ultrasound guidance Performing this technique under ultrasound guidance is recommended as it makes the procedure safer and more effective allowing real-time visualization of needle positioning and technique application

Most studies on US-PNM have focused on pain treatment in patients but some studies have explored its benefits in healthy individuals For instance De-la-Cruz-Torre et al demonstrated that applying this procedure to the sciatic nerve can increase hamstring flexibility De-la-Cruz-Torres et al also reported an increase in the performance of the flexor hallucis longus muscle in dancers Álvarez-Prats et al showed an improvement in quadriceps muscle strength after performing electrical stimulation on the femoral nerve and Gallego-Sendarrubias et al suggested an enhancement in performance skills in soccer players by applying the neuromodulation procedure to the femoral nerve before specific strength training

Overall the literature suggests that US-PNM intervention improves strength levels but the results should be confirmed with future research due to sample size limitations and short-term evaluations Additionally there are currently no studies on the application of US-PNM in a sample of CF athletes Therefore the objective of this study is to analyze the effectiveness and duration of the effects of two US-PNM protocols applied to the axillary and suprascapular nerves on shoulder rotation strength in healthy CF athletes
Detailed Description: The study aims to

Analyze whether 3 sessions of ultrasound-guided percutaneous neuromodulation US-PNM are more effective than 1 session of US-PNM for shoulder rotation muscle strength in healthy CrossFit athletes
Analyze whether the US-PNM intervention has a positive effect on the ability to perform a one-repetition maximum 1RM in a functional CF movement such as the Shoulder Press in healthy CrossFit athletes

To achieve this a randomized clinical trial is proposed with three study groups

Control group no intervention will be performed
Experimental group 1 session US-PNM will receive 1 session of US-PNM
Experimental group 3 sessions US-PNM will receive 3 sessions of US-PNM with one week of separation between each session

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None